Tuesday, November 27, 2012

• Will This New Orphan Drug Go the Distance?at Motley Fool (Tue, Nov 27)
• ENDOCYTE INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Tue, Nov 27)
• EU reviews cancer drug from Merck and EndocyteAP (Tue, Nov 27)
• Merck and Endocyte Announce Acceptance for Review of European Marketing Authorization Applications for Vintafolide and Companion Diagnostic Etarfolatide for Folate-Receptor Positive Platinum-Resistant Ovarian CancerBusiness Wire (Tue, Nov 27)

Monday, November 26, 2012

• Has Merck Become the Perfect Stock?at Motley Fool (Mon, Nov 26)

Tuesday, November 20, 2012

• Endocyte Initiated at Buy and 4 Analyst-Initiated Shares to Trackat Wall St. Cheat Sheet (Tue, Nov 20)
• 5 Biotech Stocks Rising on Unusual Volumeat TheStreet (Tue, Nov 20)

Tuesday, November 13, 2012

• ENDOCYTE INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Nov 13)

Thursday, November 1, 2012

• Endocyte Management Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Nov 1)
• Endocyte actively recruiting patients for the Phase 3 PROCEED trialat theflyonthewall.com (Thu, Nov 1)
• ENDOCYTE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Thu, Nov 1)

Tuesday, October 30, 2012

• ENDOCYTE INC Files SEC form 8-K, Other EventsEDGAR Online (Tue, Oct 30)

Tuesday, October 16, 2012

• A Puny Drug Deal for Blockbuster Indicationsat Motley Fool (Tue, Oct 16)

Monday, October 15, 2012

• ENDOCYTE INC Files SEC form 8-K, Other EventsEDGAR Online (Mon, Oct 15)

Friday, September 28, 2012

• Healthcare Business Recap: Achillion’s Hepatitis Results, Endocyte Drug Gets Orphan Statusat Wall St. Cheat Sheet (Fri, Sep 28)

Wednesday, September 26, 2012

• EC grants orphan designation to Endocyte ovarian cancer diagnosis methodat theflyonthewall.com (Wed, Sep 26)

Wednesday, August 29, 2012

• 4 Low-Debt Pharmaceutical Stocks Backed By Analystsat Seeking Alpha (Wed, Aug 29)

Thursday, August 23, 2012

• 5 Pharmaceutical Companies With Phase III Clinical Study Catalysts During The Next 4-18 Monthsat Seeking Alpha (Thu, Aug 23)

Monday, August 13, 2012

• ENDOCYTE INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, Aug 13)

Tuesday, August 7, 2012

• Drugs Are Quickat Seeking Alpha (Tue, Aug 7)

Thursday, August 2, 2012

• Endocyte, Inc's CEO Discusses Second Quarter Results - Earnings Call Transcriptat Seeking Alpha (Thu, Aug 2)
• ENDOCYTE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Thu, Aug 2)
• Insiders Love These 3 Highly Liquid Drugmakersat Seeking Alpha (Thu, Aug 2)

Thursday, July 26, 2012

• ENDOCYTE INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online (Thu, Jul 26)

Wednesday, July 25, 2012

• Earnings Preview: Merck & Co.AP (Wed, Jul 25)

Add ECYT News to My Yahoo!